Titlebook: Antimicrobial Resistance; A Crisis in Health C Donald L. Jungkind,Joel E. Mortensen,Gary B. Calan Book 1995 The Editor(s) (if applicable) a

只看該作者 · 發(fā)表于 2025-3-25 06:12:15

0065-2598 cribed. Today it is an uncommon event for a clinical laboratory to isolate an S. aureus that is sensitive to penicillin. Other gram-positive strains of bacteria978-1-4757-9205-8978-1-4757-9203-4Series ISSN 0065-2598 Series E-ISSN 2214-8019

只看該作者 · 發(fā)表于 2025-3-25 09:46:36

只看該作者 · 發(fā)表于 2025-3-25 15:41:17

Lumped-Driven Method for Motion Controllopment of resistance on the part of some fungal pathogens. From amphotericin B we have expanded to multiple new classes of drugs, with multiple alternatives within those classes. However, we have still not reached the optimal agents which are fungicidal, minimally toxic, and can be administered eit

只看該作者 · 發(fā)表于 2025-3-25 16:47:45

Book 1995Shortly after the widespread introduction of penicillin in the early 1940s, the first strains of penicillin-resistant staphylococci were described. Today it is an uncommon event for a clinical laboratory to isolate an S. aureus that is sensitive to penicillin. Other gram-positive strains of bacteria

只看該作者 · 發(fā)表于 2025-3-25 22:21:39

Donald L. Jungkind,Joel E. Mortensen,Gary B. Calan

只看該作者 · 發(fā)表于 2025-3-26 02:54:57

只看該作者 · 發(fā)表于 2025-3-26 07:44:19

Introduction to Integrated Opticss agent. These include prevention of intracellular drug accumulation, alteration in the target of the drug, and production of a drug-inactivating enzyme. The relative importance of each of these mechanisms varies depending upon the organism involved, the antimicrobial agent, and the location of the

只看該作者 · 發(fā)表于 2025-3-26 11:47:43

S. K. Kurtz,S. D. Kozikowski,L. J. Wolframs 2 and 3 (figure 1). Imipenem, the first commercially-available carbapenem, (Merck Sharp and Dohme) has been used for nearly 10 years and is now being joined by a second agent, meropenem (Zeneca/Sumitomo). The development of a third carbapenem, biapenem (Lederle) has recently been discontinued. In

只看該作者 · 發(fā)表于 2025-3-26 13:20:33

只看該作者 · 發(fā)表于 2025-3-26 17:38:24

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 20:33
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved